AMAZE 8: A Research Study Investigating How Well the Medicine NNC0487-0111 Compared to Semaglutide Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

NCT07400107 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

1000

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Overweight
Diabetes Mellitus, Type 2

Interventions

DRUG: NNC0487-0111
DRUG: Semaglutide
DRUG: Placebo (matched to NNC0487-0111)
DRUG: Placebo (matched to semaglutide)

Sponsor

Novo Nordisk A/S